Mucormycosis in patients with COVID-19: A cross-sectional descriptive multicentre study from Iran.

Farzad Pakdel Kazem Ahmadikia Mohammadreza Salehi Azin TabariRozita JafariGolfam MehrparvarYasaman Rezaie Shahin Rajaeih Neda Alijani Aleksandra BaracAlireza AbdollahiSadegh Khodavaisy

Published in: Mycoses (2021)

Clinicians should be aware that mucormycosis may be complication of COVID-19 in high-risk patients. Poor control of diabetes mellitus is an important predisposing factor for CAM. Systematic surveillance for control of diabetes mellitus and educating physician about the early diagnosis of CAM are suggested.

Keyphrases

end stage renal disease
coronavirus disease
ejection fraction
sars cov
newly diagnosed
primary care
chronic kidney disease
public health
prognostic factors
palliative care
cross sectional
glycemic control
adipose tissue
skeletal muscle
patient reported